| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Atrial fibrillation | 94 | 30 | |
| Prevent blood clotting | 83 | 50 | |
| Pulmonary embolism | 21 | 6 | |
| Deep vein thrombosis | 5 | 3 | |
| Antiphospholipid antibody syndrome | 3 | 5 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Bruising | 4 | |
| Balance problems | 1 | |
| Excessive bleeding | 1 | |
| Fatigue | 1 | |
| Leg cramps at night | 1 | |
| Muscle spasms | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 3 | |
| Mild | 10 | |
| None | 61 |
Member evaluations
Farmami
evaluated on Oct 19, 2018
- Perceived effectiveness for atrial fibrillation: Can't tell
- Side effects: None
nacona
evaluated on Jan 08, 2017
- Perceived effectiveness for deep vein thrombosis: Major
- Side effects: None
jr42
evaluated on Aug 15, 2017
- Perceived effectiveness for Prevent blood clotting: Major
- Side effects: None